Pharmaceutical News and Articles

ACC: Screening Mammograms + AI May ID Cardiovascular Disease

Automated deep learning-based quantification of breast arterial calcification (BAC) on routine screening mammograms may allow for opportunistic screening for ca

Obesity More Likely Among Kids Of Obese Moms, Smokers

A mom s health and lifestyle choices can affect her kids risk of obesity as adults, a new study says. Specifically, a child is 3 to 4 times more likely to becom

U.S. Foreign Aid Cuts Could Devastate Global Progress Against HIV/AIDS

HIV could explode worldwide in the wake of U.S. cuts to foreign aid, resulting in millions of AIDS deaths and soaring rates of infection, a new analysis says. P

Scent Test Can Sniff Out Cognitive Decline

The nose might know whether a person is showing early signs of dementia or Alzheimer s disease, a new study says. score lower on a peel-and-sniff test than peop

Heart Problems Linked To Brain Shrinkage

Heart disease might contribute to the sort of brain shrinkage seen in dementia, a new study says. People with early signs of heart problems are more likely to h

Chinese Woman Is Third Person To Get a Gene-Edited Pig Kidney

A Chinese woman is the third person in the world living with a gene-edited pig kidney, and nearly three weeks after surgery, doctors say she s doing well. The w

FDA Approves Vykat XR (diazoxide choline) to Treat Hyperphagia in Prader-Willi Syndrome

Tuberculosis on the Rise Again in the United States

Preliminary data released this month by the U.S. Centers for Disease Control and Prevention indicate that more than 10,300 tuberculosis (TB) cases were reported

2009 to 2019 Saw Increase in Avoidable Mortality in United States

and across most causes of illness throughout the U.S. before and during the COVID-19 pandemic, the authors write. This is in stark contrast to improving trends

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program

Omeros Corporation (Nasdaq OMER) today reported that clinical trial site activation for enrollment is underway for the company s Phase 3 program evaluating zalt